# YESAFILI
> **BLA761274** · Biologics License Application · Sponsor: BIOCON BIOLOGICS INC · Approved 2024-05-20
## Drug
- **FDA Application Number:** BLA761274
- **Application type:** Biologics License Application
- **Brand name:** YESAFILI
- **Generic name:** Aflibercept-Jbvf
- **Active ingredients:** AFLIBERCEPT-JBVF
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BIOCON BIOLOGICS INC
- **First approval:** 2024-05-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761274)
---
*MORVS · CC0 1.0*